CASE STUDY

Why Polly CRISPR Screening is Better than MAGeCK VISPR

Key Highlights

- CRISPR screening is performed to find gene targets for diseases.

- The conventional tools available for processing CRISPR screening data are script based.

- They are not user friendly, their installation and usage are complicated and processing power can be a limitation.

- Polly CRISPR screening overcomes these issues because it is a cloud-based tool with an interactive interface having many capabilities.

‍

All Case Studies

Oncology Company Achieves ~80% Acceleration in Gene Target ID/ Validation
Pharma-AI Collaboration Drives ~$3M Cost Reduction by Using Highly Curated Public Data
Leading Oncology Company Uses Elucidata’s Drug OmixAtlas to Drive Drug Discovery
Polly PeakML Accelerates Biological Insight Derivation from Untargeted Metabolomics Analysis
Cutting- Edge Cancer Tx Accelerated Target ID by 75% using ML & Curated Biomolecular Data
Cloud Processing of Metabolomics Data
Accelerate Cell-Type Annotation of scRNA-seq Data
Predicting Survivability of Patients with Liver Hepatocellular Carcinoma
Integrated Metabolomics and Transcriptomics Profiling
Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
Why Polly CRISPR Screening is Better than MAGeCK VISPR

Other Resources

WebinarsWhitepapersBlogsDocumentationDatasetsSolution Briefs
Polly
Features
Technology
Data on Polly
Customer Success
Solutions
Pipeline Solutions
Curation on Demand
Applications
ML Solutions
BY ROLE
Biologists
Bioinformaticians
Data Custodians
Leadership
COMPANY
About Us
Team
Mission
Careers

© All Rights Reserved, 2023

Privacy PolicyTerms of ServiceWebsite Terms of Service